AXM Pharma, Inc. Company Review & Valuation
About AXM Pharma, Inc.
As of October 4, 2018, AXM Pharma, Inc.
was acquired by AS Industries Cameroon in a reverse merger transaction.
AXM Pharma, Inc.
produces, markets, and distributes pharmaceutical products in China.
The company provides Asarone, an anti-septic, anti-inflammatory, asthma reducing, and coughs prevention medicine for the treatment of infantile pneumonia, child pneumonia, adult bacterial pneumonia, and chronic and acute bronchitis; and Lifupeng for treatment of tuberculosis.
It also offers Weifukang, an antiseptic cream for cleansing acne; and for relieving the symptoms of eczema, psoriasis, and other skin irritations, such as contact dermatitis.
In addition, the company provides Whisper, a feminine hygiene product; Qiyao Diabetes Capsule, an herbal formulation used as an adjunctive therapy for Type II diabetes; children's vitamin and vitamin supplements; anti-depression and anti-fatigue compound; Soluleaves, an oral drug delivery technology; Elegance, a menstrual relief lotion; LiveComf, a compound sulfur cream used to alleviate dermatitis, seborrheica, scabies, acne, and eczema; Bodyward, a tablet to treat allergy caused by penicillin; Reheal, a capsule used to treat reduced memory capacity and impairment of cerebral function caused by acute/chronic cerebrovascular disease, cerebral trauma, and toxic cerebral disease; and LifeGate, an anti fatigue capsule used for enhancing energy and vitality.
It owns 42 permitted and licensed formulas, which company has the right to manufacture and distribute in China.
The company was founded in 1999 and is headquartered in City Of Industry, California.